2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Brain Biopsy
In the realm of cancer research, brain biopsy stands as a pivotal procedure, particularly in the study of brain tumors. This surgical technique involves extracting a minute tissue sample from the brain for microscopic analysis. By unraveling the molecular and genetic intricacies of these samples, researchers gain valuable insights into tumor classification, progression, and potential treatment avenues. Brain biopsies serve as diagnostic cornerstones, aiding in the precise identification of tumor types and informing prognostic assessments. Moreover, they fuel the development of targeted therapies, tailored to combat the specific characteristics of individual tumors. Through continuous refinement of biopsy techniques, researchers strive to enhance our understanding of brain cancer and pave the path towards more effective treatment modalities, fostering optimism for improved patient outcomes in the face of this challenging disease.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China